The completion of the first triage test clinical validation study marks a huge milestone in medical diagnostics. The study was conducted by the American Medical Association (AMA) in partnership with the Association for the Advancement of Medical Instrumentation (AAMI). This new test, known as the Triage Test, is intended to arm medical providers with the knowledge they need to quickly and accurately diagnose a variety of illnesses.
The Triage Test is a diagnostic algorithm that takes patient information and medical history to determine the most likely diagnosis. It collects medical symptoms from the patient and compares it to a database of similar diseases. The results can then be used to pinpoint a possible illness and inform treatment decisions.
The clinical validation study, which took place between January and March of 2020, was conducted by the AMA and AAMI on a group of participants suffering from a range of illnesses. The tests results were compared to the standard patent-disease test, with accuracy results hovering around 95%.
The use of the Triage Test has the potential to save time, and lives, when diagnoses are required quickly. Currently, the test is available in the U.S. and select other countries. It is hoped that the Triage Test will become widely available in the future.
The success of the first-ever triage test clinical validation study is a huge step forward in the development of medical diagnostics. This test has the potential to revolutionize how medical practitioners diagnose and treat illnesses. Medical professionals should no doubt take note of the results of this clinical study, and use the data to inform their decisions in the future.